bis-(2,4-dichloro-phenyl)-iodonium ; chloride | 34563-73-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: bis-(2,4-dichloro-phenyl)-iodonium ; chloride
• 英文别名: Bis-(2,4-dichlor-phenyl)-jodonium; Chlorid；Feniodium chloride；bis(2,4-dichlorophenyl)iodanium;chloride
• CAS: 34563-73-0
• 化学式: C₁₂H₆Cl₄I*Cl
• 分子量: 454.349
• InChiKey: VWMVVFFLQCUGKR-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -0.57
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  五氯酚 、 bis-(2,4-dichloro-phenyl)-iodonium ; chloride 以54%的产率得到1,2,3,4,5-五氯-6-(2,4-二氯苯氧基)苯
  参考文献：
  名称：

  Synthesis, Structure Verification, and Chromatographic Relative Retention Times for Polychlorinated Diphenyl Ethers

  摘要：

  Fifty-four polychlorinated diphenyl ether (PCDEs) congeners were synthesized, and their structures were confirmed by mass spectrometry and proton magnetic resonance spectroscopy. The gas chromatographic relative retention times (RRT) for the PCDEs were determined relative to a reference standard, [C-13-3,3',4,4']-tetrachlorobiphenyl (PCB 77) on the fused silica capillary columns of SE-54 and OV-1701. The retention times for PCDEs increased with the increasing number of vicinal chlorines within a series of isomers. The chlorine substitution patterns of PCDEs were used to develop a method for predicting RRTs for congeners that were not synthesized.

  DOI：

  10.1021/es00056a024

文献信息

• Preparation of Polychlorinated Phenoxyphenols as Model Compounds of Impurities in Technical Chlorophenol Formulations
  作者：Tarmo Humppi

  DOI：10.1055/s-1985-31383

  日期：——

  The synthesis of polychlorinated phenoxyphenols (PCPPs) by three methods is described: condensation of chlorinated guaiacols with chlorobenzene or chlorofluorobenzenes in the presence of base, followed by O-demethylation; reaction of chlorinated diphenyliodonium salts with chlorinated guaiacols, or of 4,4′-dimethoxydiphenyliodonium salts with chlorophenols, followed by O-demethylation; chlorination of lower-chlorinated phenoxyphenols.

  描述了通过三种方法合成多氯化酚氧基酚（PCPPs）：在碱存在下，将氯化香豆素与氯苯或氯氟苯缩合，随后进行O-去甲基化；氯化的二苯基碘盐与氯化香豆素反应，或4,4'-二甲氧基二苯基碘盐与氯酚反应，随后进行O-去甲基化；氯化低氯化酚氧基酚。
• Diagnostic/therapeutic agents
  申请人：Klaveness Jo

  公开号：US20050002865A1

  公开（公告）日：2005-01-06

  Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.

  可定位的诊断和/或治疗活性剂，例如超声对比剂，包括悬浮在水载体液中的报告物，该报告物包含含气体或生成气体的材料，该剂能够与目标形成至少两种结合对。
• Methods and devices for the treatment of ocular conditions
  申请人：deJuan Eugene

  公开号：US20060110428A1

  公开（公告）日：2006-05-25

  Featured is a method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at least two of the following bioactive agent delivery methods (A)-(C): (A) implanting a sustained release delivery device comprising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more bioactive agents subretinally; and (C) instilling (e.g., injecting or delivering by ocular iontophoresis) one or more bioactive agents into the vitreous humor of the eye.
• METHODS AND DEVICES FOR THE TREATMENT OF OCULAR CONDITIONS
  申请人：deJuan Eugene

  公开号：US20110159073A1

  公开（公告）日：2011-06-30

  Featured is a method for instilling one or more bioactive agents into ocular tissue within an eye of a patient for the treatment of an ocular condition, the method comprising concurrently using at least two of the following bioactive agent delivery methods (A)-(C): (A) implanting a sustained release delivery device comprising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more bioactive agents subretinally; and (C) instilling (e.g., injecting or delivering by ocular iontophoresis) one or more bioactive agents into the vitreous humor of the eye.
• US3944498A
  申请人：——

  公开号：US3944498A

  公开（公告）日：1976-03-16